Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
drug delivery
Pharma
Handa's Cabometyx formulation no threat to Exelixis: analysts
Still, various factors mean the nod for Handa’s Cabometyx reformulation is unlikely to pose a threat to Exelixis, analysts have said.
Fraiser Kansteiner
Sep 11, 2026 2:06pm
NICE rebuffs Gilead's twice-yearly PrEP option
Sep 10, 2026 10:12am
Daiichi unit recalls 3 epinephrine lots after complaints in US
Sep 4, 2026 11:12am
Sanofi sues Pfizer, Moderna over mRNA patents
Jul 15, 2026 3:32pm
Kimball makes $103M bid to grow its CDMO footprint in EU, India
Jul 1, 2026 10:22am
Vertex taps Halozyme in $15M upfront biologics drug delivery deal
Apr 7, 2026 10:17am
